UFP Technologies Inc

UFP Technologies Inc(UFPT)股票分析

$295.990

-1.332 (-0.45%)收盤時

Loading chart…
最高
297.120
開盤
293.610
成交量加權均價
294.42
成交量
112.11K
市值
1.98B
最低
290.150
成交金額
33.01M
企業價值/稅息折舊攤銷前利潤(TTM)
17.88

UFP Technologies, Inc. is a designer and custom manufacturer of solutions for medical devices, sterile packaging, and other engineered custom products. The Company’s single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. Its manufacturing operations consist primarily of cutting, routing, compression and injection molding, vacuum-forming, micro-molding, thermoforming, laminating, radio frequency and impulse welding, and assembling. It also engineers components for automotive use in interior trim and structural applications. These components are produced using a compression molding process to create functional composites consisting of various materials such as polypropylene/fiberglass panels, nonwovens, and fabrics. It also develops and manufactures precision thermo-formed and heat-sealed polymer components.

AI 分析 of UFP Technologies Inc (UFPT)

持有

UFP Technologies Inc is currently a hold. The stock has shown a strong performance with a year-to-date change of +30.56% and a one-year change of +47.86%. However, the RSI is at 45.54, indicating it is neither overbought nor oversold, suggesting caution. The forward P/E ratio of 21.83 is reasonable compared to its growth potential, but insider selling activity raises some concerns. The main risk is the significant selling by hedge funds, which has increased by 2780% over the last quarter, indicating potential bearish sentiment.

分析師評級(1)

買進
1 買進
0 持有
0 賣出
目前: 295.99
最低
—
平均
—
最高
—

Lake Street

2025-08-06

目標價

$289

買進

Raymond James

2025-03-28

目標價

—

持有

Lake Street

2024-07-17

目標價

$392

強烈買進

Lake Street

2024-07-02

目標價

$344

強烈買進

Lake Street

2024-06-28

目標價

$300

強烈買進

估值指標

UFP Technologies Inc(UFPT)目前預期本益比為 21.83,5 年平均預期本益比為 26.26。

預期本益比

合理
5 年均值 P/E
26.26
目前P/E
21.83
高估
32.87
低估
19.66

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
15.65
目前EV/EBITDA
17.88
高估
19.06
低估
12.24

預期股價營收比

合理
5 年均值 P/S
2.81
目前P/S
3.22
高估
3.63
低估
2.00

Alphio AI 對 UFPT 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%UFPT

$410.08

情境價格

基

基準

基準 · 50%UFPT

$357.81

情境價格

悲

悲觀

悲觀 · 25%UFPT

$311.33

情境價格

持有 UFPT 的大戶

A

Annex Advisory Services, LLC

+ 持有UFPT

+3.21%

3個月報酬率

B

Boston Trust Walden National Association

+ 持有UFPT

-2.40%

3個月報酬率

事件時間軸

2026-08-03 (ET)

16:30:00

UFP Technologies Reports Q2 Revenue of $174M, Beating Expectations

2026-05-04 (ET)

16:50:00

Company Reports Q1 Revenue of $154.2M, Below Expectations

2026-02-27 (ET)

13:20:00

Analysis of Company's 3-5 Year Financial Targets

2026-02-24 (ET)

16:40:00

Company Reports Q4 Revenue of $148.915M, Below Consensus

2025-12-02 (ET)

09:11:00

UFP Technologies CEO R. Jeffrey Bailly to Retire in 2026, Transitioning to Executive Chairman

資訊

UFPT 常見問題 —— 由 Alphio AI 解答

UFP Technologies, Inc. is a designer and custom manufacturer of solutions for medical devices, sterile packaging, and other engineered custom products. The Company’s single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. Its manufacturing operations consist primarily of cutting, routing, compression and injection molding, vacuum-forming, micro-molding, thermoforming, laminating, radio frequency and impulse welding, and assembling. It also engineers components for automotive use in interior trim and structural applications. These components are produced using a compression molding process to create functional composites consisting of various materials such as polypropylene/fiberglass panels, nonwovens, and fabrics. It also develops and manufactures precision thermo-formed and heat-sealed polymer components. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

UFP Technologies Inc is currently a hold. The stock has shown a strong performance with a year-to-date change of +30.56% and a one-year change of +47.86%. However, the RSI is at 45.54, indicating it is neither overbought nor oversold, suggesting caution. The forward P/E ratio of 21.83 is reasonable compared to its growth potential, but insider selling activity raises some concerns. The main risk is the significant selling by hedge funds, which has increased by 2780% over the last quarter, indicating potential bearish sentiment.

1 analysts cover UFPT: 1 rate it Buy, 0 Hold and 0 Sell.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易